Fig. 1From: Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patientsFlowchart of this study. Pca prostate cancer, DEGs differentially expressed genes, GSVA gene set variation analysis, TIDE tumor immune dysfunction and exclusion, RT-qPCR real-time quantitative polymerase chain reaction, TCGA the cancer genome atlasBack to article page